MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL. · 2019
Read MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. by Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6421700.txt.
Description
Weng and co-authors report a breast cancer study in Molecular Cancer. Triple-negative breast cancer has few treatment options and a poor outlook. The team traced a signal chain that helps it grow and spread.
A gene called MCT-1 acts as an on-switch in these tumors. It lowers miR-34a, which frees interleukin-6 signals to flow. That chain drives shape change, stem-like traits, and a tumor-friendly macrophage state. High MCT-1 marked poor outcomes in patients, they report. Blocking parts of the chain may aid this hard cancer, the authors argue.
Catalog record
| CREATOR | Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |